Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-ACVBP vs R-CHOP with PET-driven strategy in high-risk DLBCL
NCT00498043Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jul 2007
- Primary completion
- Oct 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in diffuse large B-cell lymphoma (DLBCL), sponsored by Hospices Civils de Lyon. Started Jul 2007; status: completed.
02
Drugs
rituximab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00498043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498043.